Financhill
Buy
53

PGNY Quote, Financials, Valuation and Earnings

Last price:
$23.22
Seasonality move :
-7.9%
Day range:
$23.14 - $24.29
52-week range:
$13.39 - $40.89
Dividend yield:
0%
P/E ratio:
40.00x
P/S ratio:
2.01x
P/B ratio:
4.54x
Volume:
1.2M
Avg. volume:
1.8M
1-year change:
-42.43%
Market cap:
$2B
Revenue:
$1.1B
EPS (TTM):
$0.58

Analysts' Opinion

  • Consensus Rating
    Progyny has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
  • Price Target Downside
    According to analysts' consensus price target of $22.14, Progyny has an estimated downside of -4.56% from its current price of $23.20.
  • Price Target Upside
    According to analysts, the highest upside price target is $30.00 representing -100% upside increase from its current price of $23.20.

Fair Value

  • According to the consensus of 10 analysts, Progyny has -4.56% downside to fair value with a price target of $22.14 per share.

PGNY vs. S&P 500

  • Over the past 5 trading days, Progyny has overperformed the S&P 500 by 7.48% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Progyny does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Progyny has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Progyny reported revenues of $286.6M.

Earnings Growth

  • Progyny earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Progyny reported earnings per share of $0.11.
Enterprise value:
1.7B
EV / Invested capital:
--
Price / LTM sales:
2.01x
EV / EBIT:
26.58x
EV / Revenue:
1.53x
PEG ratio (5yr expected):
3.47x
EV / Free cash flow:
10.85x
Price / Operating cash flow:
14.24x
Enterprise value / EBITDA:
25.43x
Gross Profit (TTM):
$246.8M
Return On Assets:
7.88%
Net Income Margin (TTM):
5.03%
Return On Equity:
11.31%
Return On Invested Capital:
11.31%
Operating Margin:
4.35%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $700.1M $1B $1.1B $280.9M $286.6M
Gross Profit $147.9M $226.4M $246.8M $62.6M $59.2M
Operating Income $19.8M $51.7M $65.5M $18.2M $12.5M
EBITDA $21.3M $53.8M $68.4M $18.8M $13.3M
Diluted EPS $0.42 $0.52 $0.58 $0.16 $0.11
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $184.6M $254.4M $401.9M $611.3M $546.3M
Total Assets $202.1M $336.7M $510.4M $726.5M $660M
Current Liabilities $74.2M $104.5M $156.9M $193.4M $208.5M
Total Liabilities $74.8M $112.6M $163.6M $211.1M $225.1M
Total Equity $127.3M $224.1M $346.9M $515.4M $434.9M
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations $37.7M $202.7M $164.6M $54.2M $44.5M
Cash From Investing -$49M -$108.3M $27.4M -$64.3M $15.4M
Cash From Financing -$8.4M -$8.8M -$258.6M -$2.4M -$63.4M
Free Cash Flow $34.6M $199M $160.4M $53.2M $42.7M
PGNY
Sector
Market Cap
$2B
$43.6M
Price % of 52-Week High
56.74%
47.61%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.67%
1-Year Price Total Return
-42.43%
-34.6%
Beta (5-Year)
1.345
0.747
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $22.79
200-day SMA
Buy
Level $21.65
Bollinger Bands (100)
Buy
Level 14.45 - 20.71
Chaikin Money Flow
Buy
Level 61M
20-day SMA
Buy
Level $22.84
Relative Strength Index (RSI14)
Buy
Level 62.06
ADX Line
Buy
Level 43.62
Williams %R
Neutral
Level -39.9685
50-day SMA
Buy
Level $19.51
MACD (12, 26)
Buy
Level 0.91
25-day Aroon Oscillator
Buy
Level 96
On Balance Volume
Neutral
Level 49.7M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (13.1752)
Buy
CA Score (Annual)
Level (1.6161)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-2.5955)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.

Stock Forecast FAQ

In the current month, PGNY has received 3 Buy ratings 7 Hold ratings, and 0 Sell ratings. The PGNY average analyst price target in the past 3 months is $22.14.

  • Where Will Progyny Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Progyny share price will drop to $22.14 per share over the next 12 months.

  • What Do Analysts Say About Progyny?

    Analysts are divided on their view about Progyny share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Progyny is a Sell and believe this share price will rise from its current level to $17.00.

  • What Is Progyny's Price Target?

    The price target for Progyny over the next 1-year time period is forecast to be $22.14 according to 10 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.

  • Is PGNY A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Progyny is a Hold. 7 of 10 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of PGNY?

    You can purchase shares of Progyny via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Progyny shares.

  • What Is The Progyny Share Price Today?

    Progyny was last trading at $23.22 per share. This represents the most recent stock quote for Progyny. Yesterday, Progyny closed at $23.20 per share.

  • How To Buy Progyny Stock Online?

    In order to purchase Progyny stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will AMD Beat the S&P 500?
Will AMD Beat the S&P 500?

High-performance and adaptive computing leader Advanced Micro Devices (NASDAQ:AMD) is…

Why Did Walmart Stock Fall?
Why Did Walmart Stock Fall?

Walmart (NYSE:WMT) tumbled in spite of strong Q4 results that…

Is Cadence Stock a Buy, Sell or Hold?
Is Cadence Stock a Buy, Sell or Hold?

Cadence Design Systems (NASDAQ:CDNS) has seen its stock move sharply…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $3T
P/E Ratio: 35x

Alerts

Sell
2
GLOB alert for Feb 22

Globant SA [GLOB] is down 27.81% over the past day.

Sell
42
CELH alert for Feb 22

Celsius Holdings [CELH] is up 27.77% over the past day.

Buy
60
HIMS alert for Feb 22

Hims & Hers Health [HIMS] is down 25.64% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock